ReviewArchives of virology2026
Liquid-liquid phase separation in the viral replication cycle: new paradigms and therapeutic opportunities.
Review in Archives of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Liquid–liquid phase separation (LLPS) has emerged as a central principle for organizing biomolecular condensates in eukaryotic cells, providing new perspectives on how viruses spatially and temporally coordinate infection. Accumulating evidence indicates that LLPS contributes to multiple stages of viral life cycles in diverse RNA and DNA viruses, including the formation of replication compartments, sites of genome packaging, and structures involved in immune modulation. In this review, we synthesize current data on how viral and host factors co-assemble into biomolecular condensates, highlight shared biophysical features and virus-specific strategies, and discuss whether these structures are causally required for efficient replication versus correlative markers of infection. We emphasize mechanistic insights into condensate composition, material state transitions, and functional consequences for viral replication, latency, and pathogenesis, as well as key experimental strengths and limitations underlying LLPS assignments. Finally, we summarize emerging therapeutic approaches that target viral condensates or their regulatory pathways, while underscoring that most LLPS-directed antiviral strategies remain at an early preclinical stage and face substantial challenges in specificity, toxicity, and delivery. A deeper mechanistic and quantitative understanding of viral LLPS will be essential to determine when condensates represent viable antiviral targets and how they can be modulated without disrupting critical host functions.
Indexed as
Identifiers
41860722What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.